A prescription that works wonders for someone else could barely work at all for you...

And that's even if you're the same age... have the same condition... and take the exact same dose. While the other person feels better, you find hardly any relief – or wind up with nasty side effects.

What gives?

You might be tempted to blame the medication itself or even something you ate. But the real culprit could be something you've had since you were born...

Your genes.

You see, genes don't just determine things like eye color, hair color, and height. They can also affect how your body handles certain medications.

And thanks to advances in genetic testing, it's possible to predict how you'll respond to a prescription before you even take the first dose.

Here's what you should know...

When it comes to how medications get processed in your body, one organ does most of the heavy lifting...

Located just below your right rib cage, your liver acts as the main detoxifier for your blood. That means it filters your blood to remove harmful substances, breaking down toxins from whatever you ingest (and even what you breathe in).

To accomplish this feat, your liver uses proteins called enzymes. Some folks have enzymes that work speedily, while others might have enzymes that work more slowly to metabolize and remove the medication from your body.

Your genes determine how efficiently certain enzymes do their jobs. And that's where pharmacogenetics comes in.

It's a mouthful of a word, but the idea behind it is simple...

Pharmacogenetics looks at how differences in your DNA affect your body's response to medications. Depending on the drug, these genetic differences can play a role in how quickly your body breaks it down... how well it works... or how large your risk of suffering side effects is.

And sometimes, those differences can lead to serious consequences...

For example, take clopidogrel, also known as Plavix. This drug prevents platelets in your blood from clumping together to form clots. Doctors usually prescribe this drug to reduce the risk of these clots causing a heart attack or stroke.

The thing is, for clopidogrel to work, it needs to be activated by the CYP2C19 liver enzyme. And some folks have variations in the CYP2C19 gene that make it harder for their bodies to activate the drug... which means decreased antiplatelet protection and an increased risk of clot formation.

But thanks to pharmacogenetics, doctors can figure out whether you need a different antiplatelet medication. And that's a big deal if you're trying to prevent a heart attack or stroke.

Clopidogrel isn't the only example, either... Genetic testing can also provide guidance on the use of certain antidepressants, pain medications, cholesterol-lowering drugs, and more.

Pharmacogenetic testing can also reduce the likelihood of bad side effects and help your doctor figure out the best dosage.

Just keep in mind that it's not solely your genes that affect how a medication works. Other factors – like your age, other prescriptions you're on, and kidney and liver function – also play a role.

Should You Get Tested?

Don't order an expensive DNA test just yet... Pharmacogenetic testing isn't necessary for everyone. But in certain situations, it might be worth discussing with your doctor. For instance, if...

  • You're starting a medication with a known gene-drug interaction.
  • Your medication isn't working as expected.
  • You're experiencing unusual side effects.
  • You're taking multiple medications, which means you have an increased risk of potentially dangerous side effects from interactions between your genes and the drugs.

The test itself is pretty straightforward. It typically involves a cheek swab, saliva sample, or blood sample. Some tests can even be done with an at-home kit.

Just be sure to check with your insurance company before scheduling a test, since coverage might vary. You don't want to be stuck with a hefty bill.

Now, of course, choosing the right medications is one thing...

But what if scientists could use the same kind of genetic information to help discover entirely new medicines?

Well, that's one of the possibilities being explored with the help of AI.

By analyzing genetic information alongside medical records and treatment outcomes, AI could help scientists uncover patterns that lead to better treatments and faster drug discoveries.

The catch, though, is data...

Even the most powerful AI supercomputer needs reliable data. Bringing all that medical information together isn't an easy feat.

That's where things get interesting – especially on the investing side...

In a recent issue of Prosperity Investor, my team and I explored a big government-backed initiative aimed at using AI to speed up scientific discoveries. We identified one company that's well positioned to benefit from the increasing demand for high-quality medical data. If you're not a subscriber, you can grab a trial subscription here.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
November 10, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.

By entering your email, you will receive Dr. David Eifrig's Health & Wealth Bulletin and occasional marketing messages. You can unsubscribe at any time. Our privacy policy.

About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top